Literature DB >> 8018663

High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis.

C R Falcon1, M Cattaneo, D Panzeri, I Martinelli, P M Mannucci.   

Abstract

We determined the prevalence of hyperhomocyst(e)inemia before and 4 hours after a methionine load (3.8 g/m2) in 80 patients (25 mean and 55 women) who had had at least one verified episode of venous thromboembolism before the age of 40 years and in 51 healthy control subjects. No patient had any of the hemostatic abnormalities known to be associated with increased risk of venous thrombosis, and all had normal renal and liver function and no evidence of neoplastic disease. Hyperhomocyst(e)inemia was defined as fasting plasma homocyst(e)ine levels or absolute postload increments of homocyst(e)ine above the normal range. According to these diagnostic criteria, 15 patients (18.8%) and 1 control subject (1.9%) had hyperhomocyst(e)inemia. In 1 of these patients only, hyperhomocyst(e)inemia could be explained by low serum concentrations of vitamin B12 and folates. The family history for venous thromboembolism was positive for 7 of the 15 patients. Family studies, performed for eight kindreds, showed that for more than half of the studied probands the abnormality was inherited. This study indicates that moderate hyperhomocyst(e)inemia is associated with an increased risk of developing venous thromboembolism at a young age and that measurements of fasting and postmethionine plasma homocyst(e)ine levels may be useful in the evaluation of patients with juvenile venous thromboembolism, particularly if their family history suggests the presence of an inherited abnormality.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8018663     DOI: 10.1161/01.atv.14.7.1080

Source DB:  PubMed          Journal:  Arterioscler Thromb        ISSN: 1049-8834


  13 in total

Review 1.  Diagnosis and management of inherited and acquired thrombophilias.

Authors:  F A Spencer; R C Becker
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

Review 2.  Inherited thrombophilia: memorandum from a joint WHO/International Society on Thrombosis and Haemostasis meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

3.  A cross-sectional study to detect the prevalence of hyperhomocysteinemia in cases of deep vein thrombosis.

Authors:  Gautam V Kamat; S C Metgud; Vishwanath M Pattanshetti; A S Godhi
Journal:  Indian J Surg       Date:  2010-11-19       Impact factor: 0.656

Review 4.  Hyperhomocysteinaemia and associated disease.

Authors:  R C Bakker; D P Brandjes
Journal:  Pharm World Sci       Date:  1997-06

Review 5.  The case for mild hyperhomocysteinaemia as a risk factor.

Authors:  G H Boers
Journal:  J Inherit Metab Dis       Date:  1997-06       Impact factor: 4.982

6.  Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion.

Authors:  A K Vine
Journal:  Trans Am Ophthalmol Soc       Date:  2000

Review 7.  Hyperhomocysteinemia and thrombosis.

Authors:  M Cattaneo
Journal:  Lipids       Date:  2001       Impact factor: 1.880

8.  Three different presentation of same pathophysiology.

Authors:  Algherbawe Mushtak; Fahmi Yousef Khan; Baidaa Aldehwe; Ahmed Abdulrahman Al-Ani
Journal:  Acta Inform Med       Date:  2012-09

9.  Cavernous sinus and generalized venous thrombosis following rhinoplasty in a young patient.

Authors:  Mohammad Motamed Shariati; Ahmad Meymane Jahromi
Journal:  World J Plast Surg       Date:  2012-07

10.  Tamoxifen reduces plasma homocysteine levels in healthy women.

Authors:  M Cattaneo; L Baglietto; M L Zighetti; D Bettega; C Robertson; A Costa; P M Mannucci; A Decensi
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.